Skip to main content

Georgia’s First Talcum Ovarian Cancer Trial Is Set To Begin

Georgia’s First Talcum Ovarian Cancer Trial Is Set To Begin

Georgia’s First Talcum Ovarian Cancer Trial Is Set To Begin

Introduction

On Monday, September 9, the trial over claims that Johnson & Johnson’s (J&J) talc-based baby powder that caused ovarian cancer to a woman is set to begin in Atlanta. In the first case of its kind, Georgia jurors will have a chance to find a link between talcum powder and ovarian cancer.

A trial before Judge Jane Morrison involves the lawsuit filed by an Atlanta resident who died of ovarian cancer in 2016 at the age of 65. The woman filed a lawsuit against J&J shortly before her death. Her adopted minor granddaughter is the named plaintiff in this case.

Georgia jury will see evidence on how the use of talcum powder products for feminine hygiene can result in ovarian cancer. The trial is expected to continue for two weeks. As of February 2016, in seven different trials in Missouri and California juries have awarded more than $5.3 billion in damages against J&J.

From decades, studies have examined the link between genital talc use and ovarian cancer. The research shows that talc particles can migrate into the ovaries, causing inflammation and leading to the growth of malignant cells resulting in ovarian cancer. 

Talcum powder allegations include that the company knew about the risks of using talcum powder for decades and failed to warn the public of the potential risk of ovarian cancer in women despite numerous scientific studies suggesting talc as a cancer-causing mineral. Rather, they chose to market the talcum powder products to women and children for hygienic use despite being aware of the risks desiring profits before consumer safety. Lawsuits also claim J&J hid the fact that talcum powder contains asbestos.

Talc defendants currently face nearly 14,000 Talcum Powder and Shower-to-Shower lawsuits, consolidated under multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation), in the District of New Jersey. The MDL is presided by Hon. Freda L. Wolfson, U.S.D.J., and Hon. Lois H. Goodman, U.S.M.J.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!